Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Change in Receivables: 2010-2025

Historic Change in Receivables for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to -$21,000.

  • ProPhase Labs' Change in Receivables rose 98.60% to -$21,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $93,000, marking a year-over-year increase of 101.41%. This contributed to the annual value of -$4.7 million for FY2024, which is 867.91% down from last year.
  • According to the latest figures from Q3 2025, ProPhase Labs' Change in Receivables is -$21,000, which was up 82.20% from -$118,000 recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Change in Receivables ranged from a high of $30.9 million in Q4 2021 and a low of -$7.7 million during Q2 2021.
  • Its 3-year average for Change in Receivables is -$374,000, with a median of -$21,000 in 2025.
  • The largest annual percentage gain for ProPhase Labs' Change in Receivables in the last 5 years was 25,412.40% (2021), contrasted with its biggest fall of 1,175.59% (2021).
  • Over the past 5 years, ProPhase Labs' Change in Receivables (Quarterly) stood at $30.9 million in 2021, then crashed by 94.02% to $1.8 million in 2022, then crashed by 195.50% to -$1.8 million in 2023, then surged by 104.88% to $86,000 in 2024, then surged by 98.60% to -$21,000 in 2025.
  • Its last three reported values are -$21,000 in Q3 2025, -$118,000 for Q2 2025, and $146,000 during Q1 2025.